PlainRecalls
CPSC Moderate Active

Samnyte Tattoo Numbing Creams Recalled Due to Failure to Meet Child-Resistant Packaging Requirement; Sold Exclusively at Amazon.com; Risk of Poisoning; Imported by Liu Xianli

Reported: December 15, 2022 Initiated: December 15, 2022 #23070

Product Description

The recall involves Samnyte Tattoo Numbing Cream sold in 60ml and contains Lidocaine 5% with Vitamin E. The product was sold in a white tube with a flip-top closure. The drug facts label is on the back.

Reason for Recall

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The tattoo numbing cream contains lidocaine, posing a risk of poisoning to young children if they ingest it.

Remedy

Consumers should immediately stop using the recalled cream and store it in a location out of reach of children. Contact Liu Xianli for instructions on how to dispose of the product to receive a full refund. Liu Xianli is contacting all known purchasers directly.

Details

Units Affected
About 9,000
Official Source
https://www.cpsc.gov/Recalls/2023/Samnyte-Tattoo-Numbing-Creams-Recalled-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Sold-Exclusively-at-Amazon-com-Risk-of-Poisoning-Imported-by-Liu-Xianli

Frequently Asked Questions

What product was recalled? ▼
The recall involves Samnyte Tattoo Numbing Cream sold in 60ml and contains Lidocaine 5% with Vitamin E. The product was sold in a white tube with a flip-top closure. The drug facts label is on the back.. Recalled by Sainite Trading (Shenzhen) Co. LTD, of China. Units affected: About 9,000.
Why was this product recalled? ▼
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The tattoo numbing cream contains lidocaine, posing a risk of poisoning to young children if they ingest it.
What should consumers do? ▼
Consumers should immediately stop using the recalled cream and store it in a location out of reach of children. Contact Liu Xianli for instructions on how to dispose of the product to receive a full refund. Liu Xianli is contacting all known purchasers directly.
Which agency issued this recall? ▼
This recall was issued by the CPSC on December 15, 2022. Severity: Moderate. Recall number: 23070.

Related Recalls

FDA Drug Moderate

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…

Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical

Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…

Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…

Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical

Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…

SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

HANDELNINE GLOBAL LLC · 2026-02-11

Explore Related Data

Vehicle Safety → Drug Information →